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The Effects of a and f1 Adrenergic Agonists and Cyclic Adenosine 
3': 5' - Monophosphate on Epidermal Metabolism 
RICHARD R. HARRIS, PH.D., AND I. c. MACKENZIE, D.D.S., PH.D. 
Dows Institute for Dental Research, College of Dentistry, The University of Iowa, Iowa City, Iowa, U.S.A. 
Continuously regenerating stratified squamous epi-
hella form an interesting model for examining mecha-
-sms controlling the balance between rates of cell for-
mation and cell maturation and death. In vitro assays of 
rates of glycolysis and amino acid incorporation of epi-
dermal sheets free from dermal contamination were used 
to examine rates of metabolism in both normal and 
hyperplastic epidermis after treatment with various ad-
renergic agonists and cAMP. 
Epinephrine and isoproterenol over the concentration 
range of 1 x lO-n to 1 X 10-5 M depressed the rates of 
glycolysis and amino acid incorporation in normal epi-
dermis. Dibutyryl cyclic AMP produced a 73 to 78% 
depression in metabolic activity and its action was en-
anced by the addition of theophylline. The a adrenergic 
agonist norepinephrine produced similar reductions. 
en epidermal samples were treated with hexadecane 
to induce a mild hyperplasia, depressant effects of iso-
proterenol and epinephrine were lost, but dibutyryl 
cyclic AMP and norepinephrine still reduced metabolic 
activity. 
The results suggest that adrenergic agents and their 
putative second messenger cAMP cause reductions in 
epidermal metabolic activity, an effect similar to their 
effects on cell proliferation, and that increased rates of 
proliferation are associated with loss of p adrenergic 
responsiveness of the epidermis. 
The maintenance of normal epithelial structure and function 
is dependent upon balanced rates of cell proliferation and cell 
maturation. The mechanism by which this balance is main-
tained is poorly understood. It has been shown that rates of 
adult epidermal cell proliferation respond to agents such as 
epinephrine [1-3], hydrocortisone [4], and histamine [5]. The 
action of these agents has been related to changes in the cyclic 
adenosine 3':5'-monophosphate (cAMP) concentration within 
the tissue [2,3;5]. These effects have been examined primarily 
in terms of in vivo and in vitro proliferative activity measured 
by 3H-thymidine labeling of DNA or by metaphase blocking 
with stathmokinetic agents. Effects on other aspects of cellular 
metabolism have received less attention. 
Using in vitro assays [6], it has been shown that increases or 
decreases in mtes of cell proliferation are related to rates of 
cellular synthetic activities in both the basal and supra basal 
strata. It therefore seemed worthwhile to investigate the effect 
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on epidermal metabolic activity of pharmacologic agents which 
are known to influence epidermal proliferation. 
MATERIALS AND METHODS 
The pharmacologic agents epinephrine, isoproterenol, norepineph-
rine, propranolol, theophylline and N"-02-dibutyryl adenosine 3':5' 
cyclic monophosphate (dibutyryl cAMP) were purchased from Sigma. 
All other chemicals used were of the highest purity commercially 
available. All specimens of epidermis used in this study were taken 
from the ears of young adult male Balb/ C mice weighing 25-30 gm. 
Animals were sacrificed at the same time of day to reduce possible 
influences of diurnal variation. Preparation of epidermal sheets and the 
assays of metabolism were carried out as previously described [6]. 
Briefly, sheets of epidermis were obtained by incubating small pieces of 
ear skin in a 1 mM solution of disodium EDT A in buffered saline, which 
allowed the removal of the epidermis from the dermis. Samples of the 
epidermal sheets so produced were examined for the presence of basal 
cells by staining with trypan blue and microscopical examination. Prior 
to assay, specimens were preconditioned in basal medium Eagle (BME) 
(Grand Island Biological) gassed with 95% O2-5% CO2 to adjust the pH 
to 7.4. 
Glycolysis Assays 
Glycolysis was determined as l'reviously described [6). Epithelial 
samples were added to incubation tubes containing 5-3H-glucose with 
0.1 ml of BME gassed with 95% O2-5% CO2 and incubated for 2 /u. at 
37°C. °H-labeled water produced by the epithelial metabolism of glu-
cose was exchanged and assayed by scintillation counting. 
Assays of Incorporation of Labeled Amino Acids 
To provide a measure of protein synthesis [6], epidermal samples 
were added to tubes containing "C-Iabeled amino acids and 0.1 ml of 
above gassed incubation medium and incubated for 2 hr at 37°C. 
Activity was terminated and protein precipitated by the addition of 
cold trichloroacetic acid. After washing, radioactivity content was de-
termined and amino acid incorporation expressed as dpm/ hr/ mg pro-
tein. 
Treatment of Tissue 
To provide hyperplastic epidermis with an increased rate of cell 
proliferation for metabolic studies mouse ears were painted daily with 
hexadecane [7] for 4 days prior to sampling. To check the development 
of hyperplasia, similarly treated animals were given vinblastin (2 mg/ 
kg body wt.) sacrificed 4 hr later and tissue processed for histological 
examination and metaphase counts. 
Incorporation of Pharmacologic Agents 
Concentration ranges used in these experiments were chosen to 
correspond to those reported in the literature, to effectively alter the 
proliferative activity of epidermal samples [1-3]. 
Epinephrine, isoproterenol, propranolol, phentolamine, dibutyryl 
cAMP, theophylline, and norepinephrine were added to the BME in 
amounts to give the stated concentrations before the medium was 
added to the incubation tubes. 
Propranolol, a specific blocker of ,8-adrenergic sites, and phentol-
amine, a specific blocker of 0: adrenergic sites, were used to test the 
specificity of the effects of epinephrine, isoproterenol, and norepineph-
rine. Dibutyryl cAMP was used to increase the intracellular cAMP 
concentration and theophylline was used as an inhibitor of phospho-
diesterase. 
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To determine whether the effect of 'epinephrine was reversible, 
epidermal sheets were incubated with 1 x 10- 6 M epinephrine for 2 hr 
and the sheets were then transferred to medium without epinephrine. 
Epidermal sheet samples were assayed for activity immediately, and 1, 
2 and 4 hr after removal from medium containing epinephrine. 
To determine whether the effects of the various agents were linear 
over time, 1 x 10- 6 M epinephrine, isoproterenol and norepinephrine 
were added to the incubation tubes and assays of glycolysis were carried 
out for 30, 60, 90, 120 and 150 min. 
RESULTS 
Incubation of epidermal samples in buffered saline containing 
1-20 mM EDTA results in the separation of the epidermis from 
the dermis along the lamina lucida [6,8). Microscopic exami-
nation of epidermal sheets obtained by EDT A splitting and 
stained with trypan blue routinely showed the presence of an 
intact layer of basal cells in both normal and hyperplastic 
states. 
The glycolytic assay was observed to approximately linear 
over 2.5 hr of incubation (Fig 1). The reduction of glycolytic 
activity produced by 1 X 10- 6 M epinephrine, isoproterenol or 
norepinephrine showed an increasing amount of inhibition with 
time. Previous work has shown that the amino acid incorpora-
tion assay is also essentially linear with time. 
The dose response curves for the effects of epinephrine, 
norepinephrine, and isoproterenol on mouse ear epidermal gly-
colysis and amino acid incorporation are shown in Fig 2, 3, and 
4. The results generally demonstrate that over the concentra-
tion range of 10- 8 to 10- 5 M there was a progressive reduction 
in the rate of glycolysis and amino acid incorporation in vitro. 
Specifically epinephrine produced a reduction in glycolysis from 
10% at 1 X 10- 8 M to 80% at 1 X 10- 5 M and in amino acid 
incorporation from 16% at 1 X 10- 8 M to 75% at 10- 5 M. 
Norepinephrine reduced glycolysis by 20% at 1 X 10- 7 M and 
67% at 1 X 10- 5 M. Amino acid incorporation was reduced over 
the concentration range of 1 X 10- 8 M (10%) to 1 X 10- 5 M 
norepinephrine (70-74%). Figure 4 shows that 1 X 10- 5 M 
isoproterenol produced an 80% reduction in glycolysis and a 
70% reduction in amino acid incorporation. The reduction of 
activity again was concentration dependent over the range 1 X 
10- 9 M to 1 X 10- 5 M. 
The fJ-blocker, propranolol, almost completely inhibited the 
effect of epinephrine (Table I). Propranolol also blocked the 
effect of isoproterenol but required a higher concentration (1 
x, 10- 5 M) than for epinephrine (1 X 10- 6 M) (Table I). Propran-
olol had no effect on the reduction of metabolic parameters 
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FIG 1. The time dependent linearity of the glycolytic assay without 
• and with the addition of 1 X 10- 6 M epinephrine 0 , isoproterenol 6, 
or norepinephrine 0 Each point represents the average of 5 animals 
± standard error. 
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FIG 2. The effects of various concentrations of epinephrine on the 
rates of glycolysis and amino acid incorporation in mouse ear epidermal 
sheets. Each point represents the average of 10 animals ± standard 
error. 
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FIG 3. The effects of various concentrations of norepinephrine on 
the rates of glycolysis and amino acid incorporation in mouse ear 
epidermis. Each point represents the average of 10 animals ± standard 
error. 
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FIG 4. The effects of various concentrations of isoproterenol on the 
rates of glycolysis and amino acid incorporation in mouse ear epidermal 
sheets. Each point represents the average of 10 animals ± standard 
error. 
caused by norepinephrine (Table I). When 1 X 10- 6 M phentol-
amine was incorporated into the media with norepinephrine an 
inhibition of the effect of norepinephrine was observed, but 
phentolamine was without effect on the metabolic reduction 
caused by epinephrine or isoproterenol (Table I). 
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TABLE 1. Effect of the adrenergic blockers propranolol and phentolamine on the reduction of metabolic activity produced by epinephrine, 
isoproterenol, and norepinephrine 
With 
propranolol 
With 
phentolamine 
Assay 
Glycolysis 
Amino acid 
incorporation 
Glycolysis 
Amino acid 
incorporation 
Glycolysis 
Amino acid 
incorporation 
Basic media Epinephrine 
277 ± 28" 156 ± 30 
370 ± 35 160 ± 20 
269 ± 26 253 ± 60 
346 ± 30 365 ± 60 
335 ± 29 lS3 ± 25 
350 ± 27 172 ± 45 
Isoproterenol Norepinephrine 
80 ± 8 123 ± 15 
201 ± 28 200 ± 18 
230 ± 19 163 ± 13 
405 ± 25 225 ± 30 
173 ± 30 286 ± 30 
200 ± 28 394 ± 43 
a The control values are the average of 30 animals ± standard error. The other values where pharmacologic agents have been added are the 
average of 10 animals ± standard error. For glycolysis the units are nanomoles glucose/hr/mg protein and for amino acid incorporation the units 
are dpm/hr/mg protein. Each agent was used at a concentration of 1 X 10- 6 M, except that propranolol was added at a concentration of 1 X 10-· 
M to inhibit isoproterenol. 
The effect of epinephrine appeared to be reversible with time 
(Table 11). Tissue incubated for 2 hr in the presence of epi-
nephrine prior to assay showed a reduction in metabolic activity 
but when subsequently incubated for various lengths of time 
(1-4 hr) in medium without epinephrine it showed a return 
towards control levels. 
. The effects of dibutyryl cAMP, theophylline and epinephrine 
on in vitro metabolic activity are shown in Table III. 1 x 10- 3 
M dibutyryl cAMP produced a 77% reduction in glycolysis and 
a 73% reduction in amino acid incorporation. Theophylline (1 
X 10- 3 M) resulted in a 30% reduction in glycolysis. Theophylline 
when combined with dibutyryl cAMP caused an 88% reduction 
in glycolysis and an 86% reduction in amino acid incorporation. 
Further, when 1 X 10- 3 M theophylline was added with 1 X 10- 6 
M epinephrine there was a greater reduction in glycolysis and 
anllnO acid incorporation than with epinephrine alone. 
The effect of the various agents on amino acid incorporation 
and glycolysis in epidermis treated with hexadecane is shown 
in Fig 5. Hexadecane treatment caused a 2-3 fold increase in 
the thickness of the nucleated cell layer and a 3- to 4-fold 
increase in both mitotic and metabolic activity. The data is 
presented as per cent of control values. Unlike normal epidermis 
(Table I) epidermal sheets prepared from hyperplastic speci-
mens did not show decreases in metabolic activity as a result of 
the addition of either 1 X 10- 6 M epinephrine or isoproterenol 
to the assay media. A 1O-fold increase in the epinephrine 
concentration was also ineffective in causing a reduction in the 
metabolic activity (unpublished results). In contrast, norepi-
nephrine and dibutyryl cAMP both retained a depressant effect 
on the metabolic activity measured. 
DISCUSSION 
A depressant effect of epinephrine and cAMP on the mitotic 
activity of epithelial tissues in vivo is well established [1-3]. 
The data presented here provide evidence that agents such as 
epinephrine and cAMP also produce a depressant effect on the 
metabolism of the epidermis. 
Previous work [6] using the differential incorporation of 
histidine and leucine has shown parallel changes in basal and 
suprabasal metabolic activity in either hyperplasia or hypopla-
sia. It therefore seems probable, although it is as yet undemon-
strated, that epinephrine, dibutyryl cAMP, and norepinephrine 
affect both basal and suprabasal metabolic activity. 
The reduction in the rate of glycolysis and amino acid incor-
poration produced by epinephrine was found to be both dose 
related and reversible. The observed return of the metabolic 
activity towards normal levels is similar to the observations of 
Bullough and Laurence [1] that the effect of epinephrine on 
mitosis was reversible with time. Although Adachi et al [9J 
have shown that the epidermal adenyl cyclase becomes refrac-
tive to further stimulation with epinephrine, the refractiveness 
does not necessarily prevent phosphodiesterase from reducing 
the intracellular cAMP concentration to a point that the met-
abolic activity will increase towards nonnallevels. 
TABLE II. The reversibility of the inhibition of glycolysis by 
epinephrine 
Time of incubation without epi· 
nephrine 
Control 
+2 hr pre-incubation with 1 X 10- 6 
M epinephrine 
Ohr 2hr 4hr 
215 ± 31" 200 ± 19 230 ± 27 
50 ± 8 88 ± 12 ISO ± 31 
" The units of each value are nanomoles/ hr/ mg protein and each is 
the average of 5 animals ± SE. 
TABLE III. Effect of dibutyryl cyclic AMP and theophylline on 
epidermal metabolism 
Control 
+ Dibutyryl cAMP 1 X 10- 3 M 
+ Theophylline 1 X 10- .1 M 
+ Dibutyryl cAMP 1 X 10- 3 M 
& theophylline 1 X 10-3 M 
+ Epinephrine 1 X 10- " M 
+ Epinephrine 1 X 10- 6 M 
Theophylline 1 X 10- 3 M 
Glycolysis 
nanomoles 
glucose/ 
hr/ mg 
protein 
286 ± 21 
64 ± 5 
200 ± 18 
35 ± 5 
143 ± 12 
76 ± 8 
Amino 
acid 
incorporation 
dpm/ hr/ mg 
protein 
550 ± 42 
150 ± 9 
480 ± 35 
79 ± 5 
269 ± 18 
181 ± 9 
Each value the average of 10 animals ± S.E. 
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FIG 5. Effect of 1 X 10- 6 M, epinephrine !:§l, isoproterenol EJ , 
norepinephrine ~ and 1 X 10- 3 dibutyryl cAMP 0 on the 
metabolism of normal and hyperplastic epidermal samples. The hyper-
plastic epidermal samples showed a 2-3 fold increase in the thickness 
of the nucleated cell layer and a 3-4 fold increase in the rates of mitosis 
and metabolic activity over control samples. Each bar represents 
activity expressed as the percent of control animals ± SE (10 animals 
per treatment cell). 
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Yoshikawa et al [3] have shown that epidermal adenyl cyclase 
responds primarily to ,B-stimulation and they have further 
shown a greater response of adenyl cyclase to isoproterenol 
than to epinephrine. We also observed a greater metabolic 
response of the tissue to isoproterenol than to epinephrine at 
similar concentrations. The inhibition of the assayed metabolic 
parameters by dibutyryl cAMP and the enhancement by theo-
phylline of the reduction produced by epinephrine suggest that 
the metabolic effects of epinephrine are mediated through 
cAMP. 
Voorhees et al and others [2,10,11] have associated decreased 
levels of cAMP with increased epidermal proliferation in con-
ditions such as psoriasis. However the effect of cAMP appears 
to be both dose and time dependent. For example, neonatal 
skin keratinocytes show a biphasic effect of cAMP [12], at low 
concentrations a stimulation of proliferation occurs [12,13] but 
at higher concentrations there is an inhibitory effect [12]. In 
adult epidermis Chopra [14] has claimed that agents which 
increase the level of cAMP also increase the "rate of matura-
tion" as assessed by the appearance of keratohyalin granules 
and others have shown a reduction in proliferation [2,10,11]. 
Further, a possible role of the underlying connective tissue in 
modifying the epidermal response to cAMP has not been in-
vestigated. Thus investigations using cell culture or neonatal 
and adul t tissues in vivo produce variable results and tend to 
confuse the issue; however, it appears that cAMP and even 
possibly cGMP may playa central role in the control of epider-
mal proliferation and maturation. 
Epidermal samples treated with hexadecane to induce hy-
perplasia did not show a reduction in metabolic activity as a 
result of treatment with epinephrine. A similar lack of effect of 
epinephrine on cell proliferation has been reported in epidermal 
tissues with a raised rate of cell proliferation, for example, in 
neonatal skin and in epidermis treated with 12-0-tetradecanoyl 
phorbol-13-acetate (TPA) [15-17]. Belman and Garte [18] have 
shown that TP A and butyric acid affect the coupling of ,B-
receptors to adenyl cyclase. Epidermal samples treated with 
hexadecane retained their response to dibutyryl cAMP. Thus 
the lack of response to epinephrine and the continued response 
to dibutyryl cAMP, which increases the intracellular cAMP 
concentration independent of the cell membrane, is perhaps to 
be explained in terms of hexadecane treatment causing altera-
tions in membrane function and particularly of ,B-receptors. In 
wound healing, membrane changes associated with changes in 
rates of proliferation have been observed by immunofluores-
cence staining [19]. As hexadecane has very weak promoting 
activity but caused a loss of response to ,B-adrenergic agents 
and as neonatal skin does not respond to ,B adrenergic agents 
[16] it may be that increased proliferation is associated with 
altered membrane function and that this altered activity may 
not necessarily be associated with promotion as has been pro-
posed [18]. 
Norepinephrine, an a-adrenergic agonist, produced a re-
sponse similar to epinephrine in the metabolic assays in both 
normal and hyperplastic epidermal sheets. Propranolol had no 
effect on the reduction of metabolic rate produced by norepi-
nephrine indicating that the effect observed was not due to a 
partial, ,B-adrenergic activity of norepinephrine. The inhibition 
of the depressant effect by phentolamine suggests that norepi-
nephrine effect is mediated through the a adrenergic receptors. 
The tissue, therefore, appears to respond to a-adrenergic ago-
nists both in normal and hyperplastic states. These observations 
are in keeping with those of Grimm and Marks [15] who showed 
a slight resflonse to epinephrine in normal epidermis and noted 
that treatment with TP A increased the response to the norepi-
nephrine. The altered coupling of the ,B-adrenergic receptors 
and continued and possibly increased response to a-adrenergic 
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agents is further evidence of membrane alterations. It has been 
proposed that there may be coupling between a and ,B adren-
ergic agents such that when one is active the affinity for the 
other is decreased and vice versa [20]. The observed response 
of hyperplasic epidermis is consistent with this suggestion. 
The findings reported here indicate that epithelial metabo-
lism responds to agents which effect rates of epithelial prolif-
eration and point to a role of surface receptors in maintenance 
of epithelial homeostasis. Further, these fmdings suggest that 
both epidermal proliferation and metabolism are controlled by 
similar mechanisms possibly involving the cyclic nucleotide 
system. These observations point to the need of further inves-
tigation, of ,B-adrenergic binding activity in relation to the long 
term effects of hyperplasiogenic agents such as hexadecane and 
TPA. 
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